LT2931275T - Aklidiniumas, skirtas naudoti fizinio aktyvumo kasdieniniame gyvenime padidinimui pacientui, sergančiam lėtine obstrukcine plaučių liga - Google Patents

Aklidiniumas, skirtas naudoti fizinio aktyvumo kasdieniniame gyvenime padidinimui pacientui, sergančiam lėtine obstrukcine plaučių liga

Info

Publication number
LT2931275T
LT2931275T LTEPPCT/EP2013/076606T LT13076606T LT2931275T LT 2931275 T LT2931275 T LT 2931275T LT 13076606 T LT13076606 T LT 13076606T LT 2931275 T LT2931275 T LT 2931275T
Authority
LT
Lithuania
Prior art keywords
aclidinium
daily life
pulmonary disease
chronic obstructive
obstructive pulmonary
Prior art date
Application number
LTEPPCT/EP2013/076606T
Other languages
English (en)
Inventor
Diana JARRETA FERNANDEZ
Maria Esther Garcia Gil
Original Assignee
Almirall S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall S.A. filed Critical Almirall S.A.
Publication of LT2931275T publication Critical patent/LT2931275T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
LTEPPCT/EP2013/076606T 2012-12-17 2013-12-13 Aklidiniumas, skirtas naudoti fizinio aktyvumo kasdieniniame gyvenime padidinimui pacientui, sergančiam lėtine obstrukcine plaučių liga LT2931275T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12382507 2012-12-17
US201361750952P 2013-01-10 2013-01-10
PCT/EP2013/076606 WO2014095663A1 (en) 2012-12-17 2013-12-13 New use of aclidinium

Publications (1)

Publication Number Publication Date
LT2931275T true LT2931275T (lt) 2022-06-27

Family

ID=47458806

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEPPCT/EP2013/076606T LT2931275T (lt) 2012-12-17 2013-12-13 Aklidiniumas, skirtas naudoti fizinio aktyvumo kasdieniniame gyvenime padidinimui pacientui, sergančiam lėtine obstrukcine plaučių liga

Country Status (21)

Country Link
US (3) US20150328194A1 (lt)
EP (1) EP2931275B1 (lt)
JP (1) JP6346618B2 (lt)
KR (1) KR20150096400A (lt)
CN (1) CN104869996A (lt)
AR (1) AR094063A1 (lt)
AU (1) AU2013363837A1 (lt)
CA (1) CA2892928A1 (lt)
DK (1) DK2931275T3 (lt)
ES (1) ES2917879T3 (lt)
HR (1) HRP20221034T1 (lt)
HU (1) HUE059569T2 (lt)
IL (1) IL239245A0 (lt)
LT (1) LT2931275T (lt)
PL (1) PL2931275T3 (lt)
PT (1) PT2931275T (lt)
RS (1) RS63476B1 (lt)
SI (1) SI2931275T1 (lt)
TW (1) TW201427660A (lt)
UY (1) UY35196A (lt)
WO (1) WO2014095663A1 (lt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ310990A (en) 1995-06-21 2000-03-27 Asta Medica Ag Pharmaceutical powder cartridge, with an integrated metering slide, and inhaler therefor
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
DE10129703A1 (de) 2001-06-22 2003-01-02 Sofotec Gmbh & Co Kg Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren
ES2195785B1 (es) 2002-05-16 2005-03-16 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2211344B1 (es) 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2232306B1 (es) 2003-11-10 2006-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2251866B1 (es) 2004-06-18 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2251867B1 (es) 2004-06-21 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
MX2007000592A (es) 2004-07-16 2008-03-04 Almirall Lab Inhalador para la administracion de farmaceuticos en polvo, y un sistema de cartuchos de polvo para uso con este inhalador.
EP2100599A1 (en) * 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2196465A1 (en) 2008-12-15 2010-06-16 Almirall, S.A. (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors

Also Published As

Publication number Publication date
AR094063A1 (es) 2015-07-08
PL2931275T3 (pl) 2022-09-05
HUE059569T2 (hu) 2022-11-28
CA2892928A1 (en) 2014-06-26
JP2016502992A (ja) 2016-02-01
DK2931275T3 (da) 2022-07-04
HRP20221034T1 (hr) 2022-11-11
AU2013363837A1 (en) 2015-06-11
US20180000798A1 (en) 2018-01-04
PT2931275T (pt) 2022-06-30
EP2931275A1 (en) 2015-10-21
JP6346618B2 (ja) 2018-06-20
US20150328194A1 (en) 2015-11-19
US20160331733A1 (en) 2016-11-17
IL239245A0 (en) 2015-07-30
TW201427660A (zh) 2014-07-16
WO2014095663A1 (en) 2014-06-26
SI2931275T1 (sl) 2022-07-29
UY35196A (es) 2014-07-31
RS63476B1 (sr) 2022-08-31
KR20150096400A (ko) 2015-08-24
ES2917879T3 (es) 2022-07-12
CN104869996A (zh) 2015-08-26
EP2931275B1 (en) 2022-06-01

Similar Documents

Publication Publication Date Title
IL232251B (en) Pharmaceutical combination for use in the treatment of type 2 diabetes patients
GB2532394B (en) Interface comprising a rolling nasal bridge portion
HK1198556A1 (en) Prediction of outcome in patients with chronic obstructive pulmonary disease
PL2708260T3 (pl) Urządzenie do leczenia chorób układu oddechowego oraz poprawiania czynności płuc
EP2790618A4 (en) ORAL DEVICE FOR SLEEP APNEA
HRP20170248T1 (hr) Aklidinij za primjenu u poboljšanju kvalitete sna kod respiratornih bolesnika
EP2861244A4 (en) TREATMENT OF SLEEP APNEA
GB201002243D0 (en) Respiratory disease treatment
GB201002224D0 (en) Respiratory disease treatment
SI2931275T1 (sl) Aklidinij za uporabo v povečanju telesne aktivnosti v vsakdanjem življenju pacienta, ki ima kronično obstruktivno pljučno bolezen
EP2826479A4 (en) TREATMENT AGENT FOR CHRONIC-OBSTRUCTIVE LUNG DISEASE
GB201218002D0 (en) Modulator of quinolinic acid for use in the treatment of a neuropathological disease
PL2526833T3 (pl) Mebel przeznaczony do siedzenia przekształcany w łóżko
EP2900832A4 (en) PROCEDURE FOR THE ADOPTION OF A MEDICAMENT FOR INHIBITING CHOLESTERAL ABSORPTION TO A PATIENT
GB201002235D0 (en) Respiratory disease treatment
GB201001893D0 (en) Respiratory disease treatment
GB201001903D0 (en) Respiratory disease treatment
GB201113521D0 (en) Patient handling bed sheet
GB201112693D0 (en) Supine sleep support
HK1155318A2 (en) Jade pillow for health care
EP2713870A4 (en) ELECTROPHYSIOLOGICAL DIAGNOSIS AND TREATMENT OF ASTHMA